Previous 10 | Next 10 |
home / stock / wxxwy / wxxwy news
2023-07-19 06:49:45 ET Summary I have a favorable opinion of WuXi Biologics' planned spin-off, which could re-rate its valuations in a positive manner and help to accelerate the future growth of the spun-off business. WXXWY's disclosures at its recent Investor Day regarding new pr...
2023-07-19 05:32:00 ET Summary The drug outsourcing services company is spinning off its WuXi XDC unit, seizing on investor enthusiasm for a new generation of highly targeted ADC drugs. WuXi XDC has filed for a Hong Kong IPO, calling itself the world’s second largest provid...
2023-06-14 06:28:00 ET Summary We’ve seen signs of improvement that are positive for the Chinese internet services sector, but that space also continues to be a place of extreme competitive aggression. As a result of the creation of economic zones, increased availability of...
2023-06-01 05:41:58 ET In response to global clients' increasing demand for contract manufacturing services, WuXi Biologics ( OTCPK:WXXWY ) notifies that it would boost production for drug substance and drug product in Germany. The investment promotes the creation ...
WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations PR Newswire DUNDALK, Ireland , May 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO)...
2023-05-08 14:56:19 ET Summary WuXi Biologics (Cayman) Inc.'s short-term and mid-term financial guidance suggests that the company's revenue and earnings growth rates will be slower than what they were in recent years. Potential financing difficulties for the company's customers a...
2023-05-04 05:21:00 ET Summary Baron Emerging Markets Fund gained 2.68% (Institutional Shares) during the first quarter of 2023, while its principal benchmark Index, the MSCI EM Index, returned 3.96%. The Fund may invest in companies of any market capitalization, and we have gener...
WuXi Biologics Releases 2022 ESG Report Detailing Its Continued Commitment to Sustainability PR Newswire The Report outlines new goals of net-zero GHG emissions across all operations by 2050 and a 10% reduction of waste intensity by 2027 compared with 2022. The Company mak...
2023-04-12 02:26:28 ET Summary The White House's announcement on drug price caps caused a significant drop in biopharma stocks during Q1 2023. The impact of drug pricing-related caps and pressure will likely be limited, and the industry is expected to adapt and find new revenue st...
WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease PR Newswire WUXI, China , March 28, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contr...
News, Short Squeeze, Breakout and More Instantly...
Wuxi Biologics Cayman Inc ADR Company Name:
WXXWY Stock Symbol:
OTCMKTS Market:
Amid the ongoing scrutiny from Congress, WuXi AppTec and its affiliates face another setback as the Biotechnology Innovation Organization...
SHANGHAI, Jan. 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufa...
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale PR Newswire By leveraging WuXiUP TM , WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing ...